期刊文献+

细胞保护蛋白在人体移植肾中的表达

Expressions of Cytoprotective Proteins for Human Renal Allografts
下载PDF
导出
摘要 目的研究细胞保护蛋白在人体移植肾中的表达情况和临床意义。方法采用免疫组化染色技术检测人体移植肾急性排斥反应(AR)、慢性排斥反应(CR)和无排斥反应(NR)3组各10例中细胞保护蛋白A20、血红素加氧酶-1(HO-1)和B细胞淋巴瘤/白血病-XL蛋白(Bcl-XL)的表达情况。结果A20、HO-1和Bcl-XL主要表达于内皮细胞、平滑肌细胞和浸润性单核细胞。A20在AR中表达强于CR〔(5.04±0.71)vs(3.20±0.64),P<0.01〕;A20在NR中不表达。HO-1在AR中表达(7.91±2.24),在CR和NR中不表达。Bcl-XL在3组中均表达(AR:10.62±3.17;CR:8.50±2.45;NR:11.03±2.77),但在CR中表达较弱;AR、NR与CR相比,差异均具有统计学意义(P<0.05);而AR组和NR组间的差异无统计学意义。结论A20和HO-1可能在AR中发挥细胞保护作用;而在CR中,A20可能是发挥保护作用的主要蛋白。 Objective To investigate the expression status and clinical significance of cytoprotective proteins to human renal allografts.Methods Expressions of cytoprotective proteins: antiapoptotic protein(A20),heme-oxygenase-1(HO-1),and B-cell lymphoma/leukemia-XL(Bcl-XL) were analyzed by immunohistochemistry and compared in 30 renal allografts,including 10 grafts undergoing acute rejection(AR),10 grafts undergoing chronic rejection(CR),and 10 nonrejecting(NR) grafts.Results Expressions of A20,HO-1 and Bcl-XL localized mainly in endothelial,smooth muscle,and infiltrating mononuclear cells.A20 expressed in grafts undergoing AR(5.04±0.71) and CR(3.20±0.64),not in NR grafts,and its expression in CR was weaker than that in AR(P〈0.01).HO-1 expressed in AR(7.91±2.24),not in CR and NR.Bcl-XL was detected in all grafts(AR: 10.62±3.17;CR: 8.50±2.45;NR: 11.03±2.77),but had a decreased expression levels in CR.Conclusion A20 and HO-1 may play protective role for AR,and A20 may be the essential protein having protective function for CR.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2007年第5期843-846,共4页 Journal of Sichuan University(Medical Sciences)
基金 国家973计划(2003CB515504) 教育部博士点基金(JYB00402051025) 上海罗氏移植基金(SRP-TF-2005002)资助
关键词 移植肾 细胞保护蛋白 A20 HO-1 Renal allografts Cytoprotective proteins A20 HO-1
  • 相关文献

参考文献10

  • 1Bach FH,Hancock WW,Ferran C.Protective genes expressed in endothelial cells:a regulatory response to injury.Immunol Today,1997;18(10):483-486.
  • 2Soares MP,Lin Y,Anrather J,et al.Expression of heme oxygenase-1 can determine cardiac xenograft survival.Nat Med,1998;4(9):1073-1077.
  • 3Lin Y,Soares MP,Sato K,et al.Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts.J Immunol,1999;163(5):2850-2857.
  • 4Hancock WW,Buelow R,Sayegh MH,et al.Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes.Nat Med,1998;4(12):1392-1396.
  • 5Bach FH,Ferran C,Hechenleitner P,et al.Accommodation of vascularized xenografts:expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment.Nat Med,1997;3(2):196-204.
  • 6Cooper JT,Stroka DM,Brostjan C,et al.A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism.J Biol Chem,1996;271(30):18068-18073.
  • 7Badrichani AZ,Stroka DM,Bilbao G,et al.Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB.J Clin Invest,1999;103(4):543-553.
  • 8Lee EG,Boone DL,Chai S,et al.Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.Science,2000;289(5488):2350-2354.
  • 9Kunter U,Floege J,Jurgensonn SA,et al.Expression of A20 in the vessel wall of rat-kidney allografts correlates with protection from transplant arteriosclerosis.Transplantation,2003;75(1):3-9.
  • 10Chandraker A,Azuma H,Nadeau K,et al.Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.J Clin Invest,1998;101(11):2309-2318.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部